There are 3397 resources available
Minimalist or maximalist? From literature to real-world data
Presenter: Paolo Zola
Session: How do we best monitor patients during follow-up?
Resources:
Slides
Webcast
Radiological imaging vs clinical examination: When less is more
Presenter: Roberto Maroldi
Session: How do we best monitor patients during follow-up?
Resources:
Slides
Webcast
Digital pathology for immuno-oncology
Presenter: Manuel Salto-Tellez
Session: Artificial Intelligence in prognostication
Resources:
Slides
Webcast
What we could learn from each tumour type to improve the management of both
Presenter: Eric Baudin
Session: Bringing together thyroid cancer and neuroendocrine tumours
Resources:
Slides
Webcast
Cognitive defects in long term IO
Presenter: Anne Rogiers
Session: Long term survivors in the era of immunotherapy of cancer
Resources:
Slides
Webcast
How to treat bone, soft tissue and GIST patients with a hereditary predisposition: A surgeon’s perspective
Presenter: Sylvie Bonvalot
Session: Genetic predisposition in patients with sarcoma
Resources:
Slides
Webcast
Individualisation of adjuvant therapy in TNBC: Who gets what?
Presenter: Valentina Guarneri
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
LBA58 - Pathological response to neoadjuvant tislelizumab (TIS) plus platinum-doublet (PtDb) chemotherapy (CT) in resectable stage II-IIIA NSCLC patients (pts) in the phase III (Ph3) RATIONALE-315 trial
Presenter: Dongsheng Yue
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Artificial Intelligence in prognostication
Resources:
Slides
Webcast
Ideal duration of IT: How to define it and what are the implications
Presenter: Teresa Amaral
Session: Long term survivors in the era of immunotherapy of cancer
Resources:
Slides
Webcast